INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,209,083 | +90.3% | 523,132 | +59.0% | 0.02% | +100.0% |
| Q2 2023 | $6,941,626 | +18.0% | 328,987 | -4.6% | 0.01% | +14.3% |
| Q1 2023 | $5,880,835 | -15.5% | 344,917 | -0.9% | 0.01% | -22.2% |
| Q4 2022 | $6,956,636 | -7.9% | 348,180 | +0.8% | 0.01% | 0.0% |
| Q3 2022 | $7,553,000 | +8.8% | 345,369 | -1.9% | 0.01% | +12.5% |
| Q2 2022 | $6,942,000 | -17.2% | 352,009 | -1.4% | 0.01% | 0.0% |
| Q1 2022 | $8,389,000 | -20.8% | 356,986 | -8.2% | 0.01% | -11.1% |
| Q4 2021 | $10,595,000 | +40.0% | 388,962 | +41.6% | 0.01% | +12.5% |
| Q3 2021 | $7,566,000 | +9.7% | 274,732 | -2.0% | 0.01% | +14.3% |
| Q2 2021 | $6,894,000 | -19.3% | 280,228 | +11.7% | 0.01% | -30.0% |
| Q1 2021 | $8,544,000 | +29.5% | 250,864 | +26.5% | 0.01% | +25.0% |
| Q4 2020 | $6,599,000 | +13.4% | 198,238 | +9.5% | 0.01% | 0.0% |
| Q3 2020 | $5,818,000 | +14.8% | 181,022 | -1.6% | 0.01% | +14.3% |
| Q2 2020 | $5,068,000 | +177.4% | 184,022 | +61.4% | 0.01% | +133.3% |
| Q1 2020 | $1,827,000 | -30.9% | 113,995 | +3.0% | 0.00% | -25.0% |
| Q4 2019 | $2,643,000 | +23.2% | 110,695 | -9.0% | 0.00% | +33.3% |
| Q3 2019 | $2,145,000 | -34.2% | 121,595 | -4.5% | 0.00% | -40.0% |
| Q2 2019 | $3,260,000 | -29.9% | 127,346 | -20.4% | 0.01% | -28.6% |
| Q1 2019 | $4,650,000 | +94.9% | 159,946 | -12.0% | 0.01% | +75.0% |
| Q4 2018 | $2,386,000 | -50.3% | 181,846 | -23.4% | 0.00% | -42.9% |
| Q3 2018 | $4,803,000 | -23.6% | 237,546 | -10.6% | 0.01% | -30.0% |
| Q2 2018 | $6,284,000 | +7.4% | 265,695 | +2.2% | 0.01% | +11.1% |
| Q1 2018 | $5,853,000 | -28.0% | 259,895 | -0.3% | 0.01% | -25.0% |
| Q4 2017 | $8,132,000 | -0.1% | 260,795 | -0.0% | 0.01% | 0.0% |
| Q3 2017 | $8,143,000 | +111.1% | 260,895 | +16.1% | 0.01% | +100.0% |
| Q2 2017 | $3,857,000 | -9.2% | 224,750 | -7.3% | 0.01% | -14.3% |
| Q1 2017 | $4,247,000 | +30.6% | 242,563 | -1.3% | 0.01% | +40.0% |
| Q4 2016 | $3,251,000 | -7.8% | 245,700 | +1.2% | 0.01% | -16.7% |
| Q3 2016 | $3,527,000 | +50.0% | 242,900 | +1.9% | 0.01% | +50.0% |
| Q2 2016 | $2,351,000 | -19.0% | 238,400 | +4.1% | 0.00% | -20.0% |
| Q1 2016 | $2,903,000 | -31.4% | 229,100 | -1.7% | 0.01% | -37.5% |
| Q4 2015 | $4,229,000 | -2.9% | 233,000 | -0.6% | 0.01% | -11.1% |
| Q3 2015 | $4,355,000 | -16.2% | 234,500 | +10.1% | 0.01% | 0.0% |
| Q2 2015 | $5,199,000 | +171.3% | 212,900 | +131.2% | 0.01% | +200.0% |
| Q1 2015 | $1,916,000 | +663.3% | 92,100 | +468.5% | 0.00% | – |
| Q4 2014 | $251,000 | +24.3% | 16,200 | +4.5% | 0.00% | – |
| Q3 2014 | $202,000 | – | 15,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |